Roche is betting on ALK7, a target that could in theory cut fat while sparing lean mass. Arrowhead, Alnylam, GSK and Novo are chasing it too.
Recap by typeshit. Full story at Fierce Pharma.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Users reported increased appetite, fatigue, more energy and insomnia, based on comments about the trial drug on social media.
Medscape covers a study of Reddit comments on the trial drug, where users reported fatigue, insomnia, more appetite and, oddly, more energy.
Loading…